The EPS projection of Aetna Inc. (NYSE:AET) for quarter ended 2016-09-30 is $2.05. Last week, the projection for EPS was $2.05 against target of $2.05, a month earlier. While 2-months ago, this projection was $2.05 versus forecast of $2.05a quarter months earlier, posting a deviation of 0%.
Aetna Inc. (NYSE:AET) posted that 18 days earlier, the share price was revised 5 times on upside. In addition, negative revisions were 2.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 1. While in last 120 and 90 days, positive revisions were 7, and 7, correspondingly.
The per-share earnings downgrade for Aetna Inc. (NYSE:AET) in the preceding 30 and 120 were 0 and 3. While in 60 and 90 days were 0, and 2, in that order.
Aetna Inc. (NYSE:AET) EPS target was $2.05 for the quarter closed 1. It was based on 12 calls. As on 2016-04-28 the EPS was $2.3. The change was $0.08, posting a deviation of 3.6%. The price projections gave a standard deviation of 0.13.
Quarterly Sales Estimates
Aetna Inc. (NYSE:AET) sales prediction for the fiscal 2017 stands at $16736.872 and the median estimate is at $16934.12. Almost 5 analysts gave sales target.
Among this, the highest sales estimate is $17072.75 while the lowest target is $15794.4 showing standard deviation of 531.392%.
As many as 5 analysts have positive sales targets revision while 5 reduced sales estimates, posting a deviation of 0%.
Last month, 5 experts have positive sales number revision. Also, 5 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast, posting a deviation of 0.513%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...